• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Canatu

6.56 EUR-0.61 %30/7 11:46
2,429 following

CANATU

First North Finland

Hardware Manufacturer

Technology

Overview
Financials & Estimates
Investor consensus
Compare
-0.61 %
-16.54 %
-14.92 %
-29.00 %
-19.80 %
-36.31 %
-32.09 %
-
-37.62 %

Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.

Read more
Market cap
228.14M EUR
Turnover
19.52K EUR
P/E (adj.) (26e)
-28.55
EV/EBIT (adj.) (26e)
-14.39
EV/S (26e)
7.32
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
8.50 EUR
Updated
2026-04-13
Disclaimer
Atte Riikola
Atte Riikola

Analyst

Latest research

Latest analysis report

Released: 2026-04-14

Latest extensive report

Released: 2026-04-14

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
ASML dropped strong Q2 figures, and the full-year outlook was raised significantly. Capacity is also being increased for the coming years. This shouldn’t be a bad thing for Canatu, at the very least. Inderes – 15 Jul 26 ASML:n Q2-tulos ylitti odotukset selvästi ja koko vuoden ohjeistusta...
7/15/2026, 6:06 AM
by Atte Riikola
30
Canatu strengthens its management team by appointing a new CTO and CMO I was chuckling a while back at the new CEO’s delivery in his first Inderes interview, but the guy has really started shaking things up pretty quickly. These are the latest moves. Based on their credentials at...
7/13/2026, 7:46 AM
19
My strong guess is that the preparation for the second reactor delivery was intended for Samsung’s Taylor factory (or Korea). It is known that Samsung moved its initial Taylor production with CNT films from 03/2026 to early 2027, i.e., 9+ months forward following the guidance given...
yesterday
by timontti
16
Slawinski’s interview with EE Times. It seems the communication strategy hasn’t really changed since Kokkonen’s time. He does, however, give a quite enthusiastic impression of himself.
7/19/2026, 6:33 PM
11
DB predicts explosive growth for ASML’s low-NA equipment
7/19/2026, 4:25 PM
by Pandakarhu
11
Intel is accelerating its 1.4nm production, with plans for mass production as early as 2028 (instead of 2029 as previously stated). This is positive news in itself from the perspective of pellicle suppliers, as the industry trend in recent years has been skewed more towards delays...
18 hours ago
by timontti
9
The previous 18A version already uses high-NA for certain layers. It’s incredible how well Intel has managed to improve yields from the struggles with 18A about 1–1.5 years ago, based on what has been made public. I would guess that pellicles are being used, but by whom?
18 hours ago
by Pandakarhu
6
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25/8
2026

Interim report Q2'26

ASML's Q2 print way ahead estimates, full-year guidance upgraded
Analyst Comment2026-07-15 08:35 by
Atte Riikola

ASML's Q2 print way ahead estimates, full-year guidance upgraded

ASML's Q2 report clearly exceeded expectations in terms of revenue, gross margin, and EPS.

Canatu
Press release2026-07-13 09:30

Canatu strengthens its executive leadership with new CTO and CMO appointments

Canatu
Press release2026-06-25 14:30

Canatu changes its leadership structure to drive efficiency and growth

Canatu

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-06-18 14:22

Canatu achieves ISO 13485 certification, strengthening readiness for medical diagnostics markets

Canatu
Regulatory press release2026-06-01 14:42

Canatu Plc – Notification under Chapter 9, Section 10 of the Finnish Securities Markets Act

Canatu
Regulatory press release2026-05-25 08:30

Canatu Plc’s new series A shares subscribed for with investor warrants have been registered with the Finnish Trade Register

Canatu
Regulatory press release2026-05-22 08:50

Canatu Plc’s new series A shares subscribed for with option rights 2024-I have been registered with the Finnish Trade Register

Canatu
Canatu announces new CEO: Maximilian Slawinski brings strong semiconductor expertise
Analyst Comment2026-05-12 08:05 by
Atte Riikola

Canatu announces new CEO: Maximilian Slawinski brings strong semiconductor expertise

The new CEO's profile is well-suited to implement Canatu's next growth phase.

Canatu
Regulatory press release2026-05-11 13:00

The Board of Directors of Canatu Plc has resolved to amend the Performance Share Plan for key employees of the group and the Employee Share Savings Plan

Canatu
Regulatory press release2026-05-11 08:00

Inside information: Canatu announces a leadership transition – Dr. Maximilian Slawinski appointed as CEO and successor to Juha Kokkonen

Canatu
Press release2026-04-30 07:30

Canatu brings its carbon‑nanotube‑based sensor technology to new applications in animal health and diagnostics through the VALABio project

Canatu
Regulatory press release2026-04-16 15:30

Resolutions of Canatu Plc’s Annual General Meeting and the organizational meeting of the Board of Directors

Canatu
ASML's Q1 result exceeded expectations, and the full-year outlook was raised
Analyst Comment2026-04-16 07:54 by
Atte Riikola

ASML's Q1 result exceeded expectations, and the full-year outlook was raised

Accelerating AI investments support ASML's outlook

Canatu
Press release2026-04-15 13:09

Inderes Equity Research: Canatu extensive report: Thin film, thick potential

Canatu
Canatu extensive report: Thin film, thick potential
Extensive research2026-04-14 21:49 by
Atte Riikola

Canatu extensive report: Thin film, thick potential

The market for Canatu's CNT-based pellicles is still emerging, and the company's position in it appears strong.

Canatu
Canatu CMD: Primed for growth
Research2026-03-27 08:50 by
Atte Riikola

Canatu CMD: Primed for growth

We believe the targets set for 2030 (revenue of 100-150 MEUR and EBIT of 25-30%) are realistically achievable

Canatu
Canatu Capital Markets Day 2026
Webcast2026-03-26 09:00

Canatu Capital Markets Day 2026

Canatu invites analysts, investors, other capital market representatives, and media to its Capital Markets Day, taking place on Thursday, 26 March 2026.

Canatu
Regulatory press release2026-03-26 08:58

CORRECTION: Inside information: Canatu announces updated strategy and long-term financial targets, transitioning to scalable value creation

Canatu
Regulatory press release2026-03-26 08:00

CORRECTION: Inside information: Canatu announces updated strategy and long-term financial targets, transitioning to scalable value creation

Canatu
Canatu targets 100-150 MEUR revenue in 2030
Analyst Comment2026-03-26 08:13 by
Atte Riikola

Canatu targets 100-150 MEUR revenue in 2030

New targets are in line with our estimates.

Canatu